![\"\"](\"https://inventivs.net/wp-content/uploads/2023/04/file-16913753466982778867-731x1024.png\"){kind=spacer}
\n The market for personalized cancer vaccine epitope selection is growing rapidly. Epitopes are the specific parts of a protein that are recognized by the immune system. By selecting the right epitopes, researchers can design vaccines that are more effective at targeting cancer cells. The market for epitope selection services is expected to reach $1.2 billion by 2025, according to a report by MarketsandMarkets.
\nThere are several factors driving the growth of the personalized cancer vaccine market. One of the main drivers is the increasing prevalence of cancer. As the population ages and lifestyles become more sedentary, the incidence of cancer is expected to continue to rise. This has led to increased investment in cancer research and the development of new treatments.
\nAnother factor driving the market is the increasing availability of genomic data. Advances in technology have made it easier and more affordable to sequence the DNA of cancer cells. This data can be used to identify the specific mutations and proteins that are unique to an individual’s cancer cells. This information can then be used to design personalized cancer vaccines that are more effective at targeting the cancer cells.
\nThe market for personalized cancer vaccines is also being driven by the increasing focus on precision medicine. Precision medicine is an approach to healthcare that takes into account an individual’s unique genetic makeup, lifestyle, and environment. By tailoring treatments to the individual, precision medicine has the potential to be more effective and have fewer side effects than traditional treatments.
\nThere are several companies that are leading the way in the personalized cancer vaccine market. These companies offer a range of services, from sequencing and analysis of genomic data to the design and production of personalized cancer vaccines. Some of the leading companies in the market include Genocea Biosciences, Gritstone Oncology, and Neon Therapeutics.
\nIn conclusion, the market for personalized cancer vaccine epitope selection is growing rapidly. Advances in technology and the increasing prevalence of cancer are driving the demand for personalized cancer vaccines. As the market continues to grow, we can expect to see more companies entering the market and more innovative treatments being developed. The future of cancer treatment is personalized, and the personalized cancer vaccine market is at the forefront of this exciting new field.\n
\n \n
The disclosure is a description of optimized cancer vaccines as well as methods for making, using, and composing vaccines. Cancer vaccines are made up of personalized cancer antigens, or portions from cancer hotspots antigens. The disclosure also relates to an automated system for selecting nucleic acid to include in a cancer optimized vaccine.
\n\n ![\"\"](\"https://inventivs.net/wp-content/uploads/2023/04/file-4403646196853417657-941x1024.png\"){kind=spacer}
\n
Peptide Epitopes
\nPersonalized Cancer Vaccines
\nMethods of Preparation
\nHotspot mutations as Neoantigens
\nNucleic Acids/Polynucleotides
\nAntigens/Antigenic Polypeptides
\nChemical Modifications
\nModified Nucleotide Sequences Encoding Epitope Antigen Polypeptides
\nUntranslated regions (UTRs),
\n3? “3?
\n\n ![\"\"](\"https://inventivs.net/wp-content/uploads/2023/04/file-7328862228407728100-714x1024.png\")
\n
Regions with a Cap of 5?” Cap
\nPoly-A Tails
\nStart Codon Region
\nStop Codon Region
\nInsertions & Substitutions
\nComputerized Systems
\nMethods of Treatment.
\nFormulations
\nKits
\nEXAMPLES
\n\n ![\"\"](\"https://inventivs.net/wp-content/uploads/2023/04/file-10898387188700238628-798x1024.png\")
\n
Example 1. “Manufacture of polynucleotides”.
\n\n ![\"\"](\"https://inventivs.net/wp-content/uploads/2023/04/file-2890507577185595487-1024x588.png\")
\n
Click here to view the patent on Google Patents.
\n","id":"cG9zdDo4ODA4","uri":"/invention-for-personalized-cancer-vaccine-epitope-selection-us20210268086a1/","title":"Invention for Personalized cancer vaccine epitope selection","tags":{"nodes":[{"name":"Patent Review"}]},"categories":{"nodes":[{"name":"Chemical Products"}]},"featuredImage":{"node":{"mediaItemUrl":"https://wp.inventiv.org/wp-content/uploads/2023/04/file-16913753466982778867.png"}}}},"pageContext":{"slug":"invention-for-personalized-cancer-vaccine-epitope-selection-us20210268086a1","neId":"8808","categories":["3D Printing","Animal Health","Apple","Artificial Intelligence","Autonomous Vehicles","Biopharmaceuticals","Blockchain Fintech","Cannabis Patents and Trademarks","Chemical Products","Communications","Consumer Products","Digital Healthcare","Electronics","Food Science Packaging","Industrial Products","Infectious Diseases","Internet","Medical Device","Metaverse","Nanotechnology","Prescription & OTC Drugs","Software","Start Up","Therapeutic Antibodies","uncategorized"],"tags":["Alphabet","Amazon","Facebook/Meta","Microsoft","Patent Review","Samsung"],"siteUrl":"https://inventivs.net"}}, "staticQueryHashes": ["764694655"]}